Skip to content

Medical Care with telemedicine of ambulant patients with diabetes mellitus type 1 and 2

Medical Care with telemedicine of ambulant patients with diabetes mellitus type 1 and 2

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00003140
Enrollment
142
Registered
2011-06-22
Start date
2011-02-14
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E10 E11

Interventions

Group 1: Intervention group: medical care with telemedicine. Patients have one visit per quarter, all necessary measurements will have on this visit (HbA1c, blood glucose, blood glucose self control,

Sponsors

Universitätsklinikum Jena
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. diabetes type 1 or type 2, access to the internet and telephone, 2. positive informed consent, 3. support in the study center at controls after study 4. duration of diabetes at least one year, 5. participation of a treatment and teaching programme,6. not achieve the treatment goal above two quarters: patients with diabetes type 1: HbA1c >=8% and /or >3 not severe hypoglycemia per week and/or 1 or more nocturnal hypoglycemia; patients with diabetes type 2: HbA1c >=8% and / or >1 not severe hypoglycemia per week

Exclusion criteria

Exclusion criteria: 1. not give their informed consent, 2. patients with indication for hospital treatment, 3. patients who are not able to fulfill the technical requirements, 4. patients with depression, 5. patients with severe concomitant diseases, 6. pregnancy

Design outcomes

Primary

MeasureTime frame
HbA1c measured at baseline, 3 and 6 months after Randomisation

Secondary

MeasureTime frame
incidence of hypoglycemia will be enquired at baseline, 3 and 6 months after Randomisation, treatment satisfaction will be detect with the DTSQ questionaire at baseline and after 6 months, diabetes dependent quality of life will be detect with the ADDQoL questionaire at baseline and after 6 months, medical costs will be calculated after 6 months

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026